Happy to represent @theMMRF at the
@HarmonynetEU General Assembly. Impressive work using big data to help patients with blood cancers. Farzad Ali from our data partner @pfizer kicks off the meeting with a glimpse of how cancer has touched his life. #bigdataforbloodcancer#mmsm
The MIF invests in the most promising companies, clinical assets, and technologies in #multiplemyeloma. @CytoImmune Therapeutics is one of them. Read about the promising new therapies driven by the MIF in our 2022 Accelerator: https://t.co/O64z29Bv6a #CancerResearch
Looking forward to speaking at PMWC 2022 next week! Come find out more about @theMMRF CureCloud and the valuable data it's generating. Track 4 Real World Evidence. June 30th, 3:30pm. @PMWCintl#PMWC22#MMSM
"Patients with multiple myeloma frequently present with substantial immune impairment and an increased risk for [Covid] infections and infection-related mortality."
https://t.co/qmQKSkm7Ig @TheLancetHaem A review by 36 experts. Of relevance to the recent passing of Colin Powell
Slots available now on phase II study of CC-92480 for patients with relapsed and refractory multiple #myeloma: https://t.co/zDQ5ZAGQY7. CC-92480 has shown a 48% response rate at therapeutic doses with convenient oral dosing. https://t.co/Uo1eT5uTB7. Please RT!
Falling a little short of our goal to raise $25k for @theMMRF through the Los Angeles 5K! We’re at $24,455! Only $545 and we’ll be there! You can donate through: https://t.co/9tUx5N2qBB! If you can’t donate, please retweet!! #MMSM#Myeloma#MultipleMyeloma#MM ❤️ @MMRFTeam4Cures